Vaxxinity, Inc. (OTCMKTS:VAXX – Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.01 and traded as high as $0.0275. Vaxxinity shares last traded at $0.0275, with a volume of 215 shares changing hands.
Vaxxinity Stock Up 45.9%
The firm’s 50-day moving average price is $0.01 and its 200 day moving average price is $0.01. The company has a market capitalization of $3.42 million, a P/E ratio of -0.14 and a beta of -74.42.
About Vaxxinity
Vaxxinity Inc is a biotechnology company focused on developing vaccines and immunotherapies for chronic diseases, including neurodegenerative conditions. The company’s approach is designed to stimulate the body’s immune system to target disease-related proteins or pathways, with the goal of addressing underlying disease biology rather than treating symptoms alone.
Vaxxinity’s research and development pipeline has included UB-311, an investigational vaccine targeting amyloid beta for Alzheimer’s disease, and UB-312, an investigational vaccine designed to target abnormal alpha-synuclein associated with Parkinson’s disease and other synucleinopathies.
Further Reading
- Five stocks we like better than Vaxxinity
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Vaxxinity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaxxinity and related companies with MarketBeat.com's FREE daily email newsletter.
